CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 01, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a...
ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system
April 03, 2018 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects...
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
March 23, 2018 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it secured a $1 million bridge financing...
Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
March 14, 2018 09:00 ET
|
CURE Pharmaceutical
LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC:CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing....
Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release)
March 05, 2018 10:30 ET
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent
March 05, 2018 07:30 ET
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
February 21, 2018 06:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced Gene Salkind, M.D. joined the company’s...
Microbubbles/Ultrasound Contrast Agents Market Worth 1,584.5 Million USD by 2024, Says Meticulous Research™
February 20, 2018 09:15 ET
|
Meticulous Market Research Pvt. Ltd.
LONDON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- The global microbubbles/ultrasound contrast agents market will grow at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024, majorly...
Pivot Provides Market Activity Update
February 13, 2018 15:09 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), a biopharmaceutical company engaged...
Pivot Pharmaceuticals Provides Corporate Update
February 12, 2018 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), a biopharmaceutical company engaged in the development...